JENIFER CALDWELL: Open Payments
NPI 1316933963 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 32 payments from 13 companies in 2025. Trend: 2023 $492 · 2024 $366 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $100 |
| Ionis Pharmaceuticals, Inc. | 3 | $75 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $73 |
| CSL Behring | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| Genentech USA, Inc. | 2 | $47 |
| ACADIA Pharmaceuticals Inc | 1 | $43 |
| Grifols USA, LLC | 2 | $42 |
Products named: Xolair, DAWNZERA, NEFFY, Andembry, AYVAKIT, AIRSUPRA, DAYBUE, Prolastin-C Liquid.
Industry payments across MT — which companies pay providers there.
